Morningstar - Mitsui Co. Ltd (8031) Mitsuiâ€™s Fiscal 2019 Earnings Trail Expectations Because of One-Off Event; Shares Overvalued

Report

Morningstar

Chokwai Lee

EUR 100.00 For Business Accounts Only

Mitsuiâ€™s Fiscal 2019 Earnings Trail Expectations Because of One-Off Event; Shares Overvalued

We continue to see no-moat Mitsui as overvalued following the fiscal year ended March's net profit of JPY 414 billion, which was down 1% year over year. Stripping out a one-off loss of JPY 20.6 billion due to the fire at Intercontinental Terminals Company in March, results were largely within our expectations. Earnings from its metal resources segment were down 35%, but this was due to the absence of a valuation gain that had lifted fiscal 2018 earnings. Mitsui otherwise got a boost from the ene...

29/04/2019 12 EN

Underlying

Mitsui & Co. Ltd

Mitsui & Co. is a general trading company engaged in a range of global business activities including worldwide trading of various commodities, arranging financing for customers and suppliers in connection with Co.'s trading activities, organizing and coordinating industrial projects, participating in financing and investing arrangements, assisting in the procurement of raw materials and equipment, providing new technologies and processes for manufacturing, and coordinating transportation and marketing of finished goods. Americas, Europe, the Middle East and Africa, and Asia Pacific trade in various commodities and conduct related business led by overseas trading subsidiaries in each region.

See profile

JP3893600001 Japan

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Chokwai Lee

Other Reports on these Companies

Pelham Smithers Associates Ltd

PSA Market Strategy: How Japan Transformed from a Bear Market to a Bull Market (and is There More to Come?)

In our 2010 Japan Perspective, written close to the nadir of the bear market, we discussed what was wrong with Japan, but also what it was starting to do right. Fourteen years on, the Nikkei 225 - though not yet Topix - has hit a new all-time high. This report looks at how Japan built on those things that were going right, while also starting to address what else needed to be done, and looks at whether more is needed to be done if the market rally is to continue from here.

February 27, 2024 February 27, 2024 1 EN

Pelham Smithers Associates Ltd

PSA ESP Software / SaaS: The Rise of Digital Invoicing in Japan

Digitisation of invoices in Japan is being boosted by particular taxation issues. This is good news for SaaS companies such as Money Forward, Sansan, Infomart and Rakus, explains Lindsay Whipp.

July 29, 2022 July 29, 2022 1 EN

TheScreener

With a more favourable environment, MITSUI improves to Positive

MITSUI (JP), a company active in the Industrial Suppliers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date December 10, 2021, the closing price was JPY 2,570.00 and its potential was estimated at JPY 2,939.08.

Free Trial

December 11, 2021 December 11, 2021 6 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Joe Gemino

Joe Gemino

Sasol Provides Full-Year Production Update

No-moat Sasol provided an update on its full-year fiscal 2019 production metrics that included relatively stable liquids production. For the full year ended June 30, Sasol produced 1,470 thousand barrels of crude oil and condensate a day compared with 1,469 mboe/d in the year-ago period. However, declines continued with the companyâ€™s natural gas production, down 4% to 130.3 billion cubic feet compared with the period ended June 30, 2018. Sasol also reported flat refined products of 31.4 mmboe/d ...

EUR 100.00

July 25, 2019 July 25, 2019 12 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Mitsuiâ€™s Fiscal 2019 Earnings Trail Expectations Because of One-Off Event; Shares Overvalued

PSA Market Strategy: How Japan Transformed from a Bear Market to a Bull Market (and is There More to Come?)

PSA ESP Software / SaaS: The Rise of Digital Invoicing in Japan

With a more favourable environment, MITSUI improves to Positive

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Sasol Provides Full-Year Production Update

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe